1.
Peter Dreger, Michael Rieger, Bärbel Seyfarth, Manfred Hensel, Michael Kneba, Anthony D. Ho, Norbert Schmitz, Christiane Pott. Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome. Haematologica 2007;92(1):42-49; https://doi.org/10.3324/haematol.10608.